Trial ID or NCT#



recruiting iconRECRUITING


To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.

Official Title

Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial A Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients With Aortic Valve Disease

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Michael Fischbein
Michael Fischbein
Cardiothoracic surgeon
Associate Professor of Cardiothoracic Surgery (Adult Cardiac Surgery) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.


Kokil Bakshi
(650) 498-1232